Associate Professor in Endocrinology @Unibo. Special interest in adrenal diseases and diabetes
Bologna, Emilia Romagna
Joined January 2012
- Tweets45
- Following197
- Followers113
- Likes78
Guido Di Dalmazi retweeted
💊SGLT2i pleiotropic effects have demonstrated efficacy across various cardiovascular conditions, ranging from acute to chronic coronary syndromes and extending to arrhythmias, valvular heart disease, cardiomyopathies, cardio-oncology, and cerebrovascular disease!
🔍Our review provides an overview of the current literature on the potential mechanisms underlying the effectiveness of SGLT2i across a wide range of cardiovascular diseases, beyond HF.
@ELS_Cardiology @ElsevierConnect @matt_armi @CarminePizzi @L_Bergamaschi
#Pharmacology #ClinicalPharmacology #DrugDevelopment #SGLT2i
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 ... sciencedirect.com/science/ar…
Guido Di Dalmazi retweeted
Hats off for the brilliant International Adrenal Cancer Symposium at @MDAndersonNews! Outstanding level of expertise and innovation. @A5_Adrenal @ENSAT_news It was an honor to share our work on circulating cell free DNA from @Bham_AT which was selected for the Abstract Award. – at Houston, TX
Honoured to be part of this wonderful meeting! Excellent scientific sessions and networking at the @MDAndersonNews in Houston
Guido Di Dalmazi retweeted
Excellent representation of our #ENSAT Executive Committee and members at the @A5_Adrenal 9th International Adrenal Cancer Symposium #IACS2024 at @MDAndersonNews in Houston (Texas) #adrenal #adrenalcancer! See you all in 2026 (in Europe)!
Congrats @DocTux92 and Kimberly for winning the poster prize on salivary cortisol profile in adrenal incidentalomas at wonderful @ENSAT_news meeting in Palma!
Guido Di Dalmazi retweeted
It’s a wrap!! It has been a wonderful event with huge participation, great science and plenty of network opportunities! Well done to local organisers Rodrigo Toledo and team @RToledoLab 👏 and the #ENS@T ExCo.
See you all next year in #Belgrade!
Guido Di Dalmazi retweeted
Congratulations to our new president-elect Cristina Ronchi @CryRonchi - first female in ENS@T history 👏👏👏 #adrenal #adrenaltumours #adrenalresearch
Guido Di Dalmazi retweeted
Did you remember to sign up for the 9th International Adrenal Cancer meeting?
Nov 22-23, 2024 in Houston, Tx USA.
Agenda and info with QR code below.
#adrenalcancer
Guido Di Dalmazi retweeted
Thanks @ENSAT_news for the opportunity, to all the contributors around Europe that made this possible and to the mastermind behind the project @gdd1982. See you all in Palma! – at Birmingham, England
Guido Di Dalmazi retweeted
🚨 SAVE THE DATE! Not to be missed the International Adrenal Cancer Symposium taking place in Houston (Texas) - see the link for details, abstract deadlines, travel grants and registration mdanderson.cloud-cme.com/cou… #adrenalcancer #adrenalresearch #cureACC @LetsCureAcc
Guido Di Dalmazi retweeted
A warm welcome to @DocTux92, who is MD, Specialist in Endocrinology and current PhD student in Endocrine Molecular Pathology at Bologna University/Sant'Orsola Policlinic (Italy). He has joined our adrenal team under the supervision of Dr @CryRonchi for a visit of 18 months.
Guido Di Dalmazi retweeted
#Hypercortisolism is worryingly underdetected among #hypertensive patients. Read our latest #survey on 78000 patients within 82 Italian centres.
@gdd1982 @Unibo
link.springer.com/article/10…
Guido Di Dalmazi retweeted
Just published on @Eur_Thyroid_J! Great effort among Italian teams to study clinical relationship between COVID 19 and subacute thyroiditis, it was an honour for me! #covid #thyroid #endocrinology
etj.bioscientifica.com/confi… – at Birmingham, England
Guido Di Dalmazi retweeted
New research: Monitoring adrenal insufficiency through salivary steroids: a pilot study by Lorenzo Tucci et al
From EJE Vol. 190, Issue 4, April 2024
Read the Open Access article here👉doi.org/10.1093/ejendo/lvae0…
Guido Di Dalmazi retweeted
Online now: @AlePreteUoB & @IrinaBancos review the pathophysiology, comorbidities and management approaches for mild autonomous #cortisol secretion rdcu.be/dFCQ0
#europeanhormoneday #becausehormonesmatter
Guido Di Dalmazi retweeted
Can salivary steroid be useful for adrenal insufficiency management? Don't miss our paper on @EJEndo!
Very proud of our work and terrific team! @gdd1982
#addison #cortisol
Monitoring adrenal insufficiency through salivary steroids: a pilot study academic.oup.com/ejendo/arti… – at Bologna, Emilia Romagna
Guido Di Dalmazi retweeted
First demnstration of efficacy of an antiangiogenetic target agent against metastatic pheochromocytoma
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, m… pubmed.ncbi.nlm.nih.gov/3840…
Guido Di Dalmazi retweeted
@ESEndocrinology concerns and actions regarding Endocrine Disrupting Chemicals #EDC commented with ESE past-president @martin_reincke, ESE president-elect @WiebkeArlt & the ESE Environmental Endocrinology Focus Area Chairs @damdimopoulou & Joseph Köhrle
nature.com/articles/s41574-0…
ALT https://www.nature.com/articles/s41574-024-00958-0
Guido Di Dalmazi retweeted
Congratulations to the winner of our Transatlantic Alliance Award, Felix Beuschlein, Switzerland! This award is presented to a recognised international leader who has made significant advancements in endocrinology research in the USA & Europe. ow.ly/V5ss50PY2az #ESEAwards
